News

This agreement will give Centocor and its Ortho Biotech Oncology R&D division affiliates the opportunity to discover and develop novel small molecule inhibitors of the fatty acid biosynthesis

Dr Egeler is a pediatric bone marrow transplantation physician and an internationally recognized authority in pediatric hemato-oncology. He brings to Kiadis Pharma over more than 20 years of

The company’s board of directors has approved a plan of complete liquidation and dissolution of the company (the plan), subject to shareholder approval. The company intends to hold

Star technology is a production technology that is particularly useful for the production of recombinant human antibodies and proteins. It has a potentially broad application and is reported

According to the company, Operetta employs its proprietary new Harmony software which provides researchers with easy-to-use building blocks for creating user configurable workflows via simple step-by-step procedures. An

“The Board of Directors and management team of IRIS International are grateful to Dick Williams for his valuable contributions during a period in which we have experienced very

With the closing, Novartis assumes ownership of certain dry powder and liquid pulmonary formulation and manufacturing assets, including capital equipment and manufacturing facility lease obligations. The sale also

Prasugrel is an investigational antiplatelet agent for the treatment of patients with acute coronary syndromes who are being managed with an artery-opening procedure known as percutaneous coronary intervention,

Impax Laboratories, a technology based specialty pharmaceutical company, applies its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the